Research programme: anti-interleukin 21 monoclonal antibodies - Novo NordiskAlternative Names: Anti-IL-21 monoclonal antibody - ZymoGenetics; IL-21 mAb; IL-21 monoclonal antibody - ZymoGenetics
Latest Information Update: 02 Mar 2011
At a glance
- Originator ZymoGenetics
- Class Monoclonal antibodies; Proteins
- Mechanism of Action Immunomodulators; Inflammation mediator modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Autoimmune disorders; Inflammation